Microbiology

  1. Designed peptides as potential fusion inhibitors against SARA-CoV-2 coronavirus infection

    1. Ke Chen
    2. Shihao Bai
    3. Xin Zou
    4. Jie Hao
    5. Lin-tai Da
    6. Ze-Guang Han

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses

    1. Fabian Schmidt
    2. Yiska Weisblum
    3. Frauke Muecksch
    4. Hans-Heinrich Hoffmann
    5. Eleftherios Michailidis
    6. Julio C. C. Lorenzi
    7. Pilar Mendoza
    8. Magdalena Rutkowska
    9. Eva Bednarski
    10. Christian Gaebler
    11. Marianna Agudelo
    12. Alice Cho
    13. Zijun Wang
    14. Anna Gazumyan
    15. Melissa Cipolla
    16. Marina Caskey
    17. Davide F. Robbiani
    18. Michel C. Nussenzweig
    19. Charles M. Rice
    20. Theodora Hatziioannou
    21. Paul D. Bieniasz

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins

    1. Yuejun Shi
    2. Jiale Shi
    3. Limeng Sun
    4. Yubei Tan
    5. Gang Wang
    6. Fenglin Guo
    7. Guangli Hu
    8. Yanan Fu
    9. Zhen F. Fu
    10. Shaobo Xiao
    11. Guiqing Peng

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion

    1. Ruochen Zang
    2. James Brett Case
    3. Maria Florencia Gomez Castro
    4. Zhuoming Liu
    5. Qiru Zeng
    6. Haiyan Zhao
    7. Juhee Son
    8. Paul W. Rothlauf
    9. Gaopeng Hou
    10. Sayantan Bose
    11. Xin Wang
    12. Michael D. Vahey
    13. Tomas Kirchhausen
    14. Daved H. Fremont
    15. Michael S. Diamond
    16. Sean P.J. Whelan
    17. Siyuan Ding

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Structural basis of a public antibody response to SARS-CoV-2

    1. Meng Yuan
    2. Hejun Liu
    3. Nicholas C. Wu
    4. Chang-Chun D. Lee
    5. Xueyong Zhu
    6. Fangzhu Zhao
    7. Deli Huang
    8. Wenli Yu
    9. Yuanzi Hua
    10. Henry Tien
    11. Thomas F. Rogers
    12. Elise Landais
    13. Devin Sok
    14. Joseph G. Jardine
    15. Dennis R. Burton
    16. Ian A. Wilson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives

    1. Ritesh Tandon
    2. Joshua S. Sharp
    3. Fuming Zhang
    4. Vitor H. Pomin
    5. Nicole M. Ashpole
    6. Dipanwita Mitra
    7. Weihua Jin
    8. Hao Liu
    9. Poonam Sharma
    10. Robert J. Linhardt

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike

    1. Jérémie Prévost
    2. Romain Gasser
    3. Guillaume Beaudoin-Bussières
    4. Jonathan Richard
    5. Ralf Duerr
    6. Annemarie Laumaea
    7. Sai Priya Anand
    8. Guillaume Goyette
    9. Mehdi Benlarbi
    10. Shilei Ding
    11. Halima Medjahed
    12. Antoine Lewin
    13. Josée Perreault
    14. Tony Tremblay
    15. Gabrielle Gendron-Lepage
    16. Nicolas Gauthier
    17. Marc Carrier
    18. Diane Marcoux
    19. Alain Piché
    20. Myriam Lavoie
    21. Alexandre Benoit
    22. Vilayvong Loungnarath
    23. Gino Brochu
    24. Elie Haddad
    25. Hannah D. Stacey
    26. Matthew S. Miller
    27. Marc Desforges
    28. Pierre J. Talbot
    29. Graham T. Gould Maule
    30. Marceline Côté
    31. Christian Therrien
    32. Bouchra Serhir
    33. Renée Bazin
    34. Michel Roger
    35. Andrés Finzi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Rapid inactivation of SARS-CoV-2 with Deep-UV LED irradiation

    1. Hiroko Inagaki
    2. Akatsuki Saito
    3. Hironobu Sugiyama
    4. Tamaki Okabayashi
    5. Shouichi Fujimoto

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Identification of unique mutations in SARS-CoV-2 strains isolated from India suggests its attenuated pathotype

    1. Shubham Gaurav
    2. Shambhavi Pandey
    3. Apurvasinh Puvar
    4. Tejas Shah
    5. Madhvi Joshi
    6. Chaitanya Joshi
    7. Sachin Kumar

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type

    1. Paul R. Lephart
    2. Michael Bachman
    3. William LeBar
    4. Scott McClellan
    5. Karen Barron
    6. Lee Schroeder
    7. Duane W. Newton

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 59 of 252 Next